Talphera, Inc. financial data

Symbol
TLPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
1850 Gateway Drive, Suite 175, San Mateo, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
ACELRX PHARMACEUTICALS INC (to 12/14/2023)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 422 % +141%
Quick Ratio 6.23 % -24.1%
Debt-to-equity 58.3 % -34.8%
Return On Equity -88.9 % +38.8%
Return On Assets -56.1 % +26.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17M shares +4%
Common Stock, Shares, Outstanding 17M shares +54.6%
Entity Public Float 12.1M USD -66.1%
Common Stock, Value, Issued 17K USD +54.5%
Weighted Average Number of Shares Outstanding, Basic 26.2M shares +140%
Weighted Average Number of Shares Outstanding, Diluted 14.3M shares +92.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.29M USD +56.8%
Costs and Expenses 16.5M USD -17.3%
Operating Income (Loss) -25.7M USD -84.7%
Nonoperating Income (Expense) 2.39M USD -50%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.83M USD +13.5%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -13.7M USD +49%
Earnings Per Share, Basic -0.45 USD/shares +84%
Earnings Per Share, Diluted -0.08 USD/shares +91.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.4M USD +81.1%
Cash, Cash Equivalents, and Short-term Investments 14M USD
Accounts Receivable, after Allowance for Credit Loss, Current 309K USD +93.1%
Inventory, Net 1.18M USD +6.03%
Assets, Current 16M USD +81.5%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 8.82M USD 0%
Other Assets, Noncurrent 20K USD -88%
Assets 24.9M USD +40.2%
Accounts Payable, Current 808K USD -33.3%
Accrued Liabilities, Current 1.74M USD -5.94%
Liabilities, Current 3.27M USD -22.4%
Contract with Customer, Liability, Noncurrent 1.04M USD -9.99%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 12.1M USD +66%
Retained Earnings (Accumulated Deficit) -452M USD -3.12%
Stockholders' Equity Attributable to Parent 12.7M USD +22.2%
Liabilities and Equity 24.9M USD +40.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.88M USD +45.1%
Net Cash Provided by (Used in) Financing Activities 12M USD
Net Cash Provided by (Used in) Investing Activities -2.73M USD -783%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 17M shares +54.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.4M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.72M USD -71.8%
Deferred Tax Assets, Valuation Allowance 100M USD +2.22%
Deferred Tax Assets, Gross 102M USD +2%
Operating Lease, Liability 100K USD -97.9%
Depreciation 200K USD -33.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 104K USD -98.4%
Property, Plant and Equipment, Gross 3.58M USD -57.8%
Operating Lease, Liability, Current 51K USD -95.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.09M USD -12.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 104K USD -93.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4K USD -99.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.04M USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 88.8M USD +5.35%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 2.84M USD +5.86%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.04M USD 0%
Additional Paid in Capital 465M USD +3.56%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 0 USD -100%
Share-based Payment Arrangement, Expense 1.21M USD -49.3%
Interest Expense 15K USD -98.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares